T cell responses to whole SARS coronavirus in humans.
Effective vaccines should confer long-term protection against future outbreaks of severe acute respiratory syndrome (SARS) caused by a novel zoonotic coronavirus (SARS-CoV) with unknown animal reservoirs. We conducted a cohort study examining multiple parameters of immune responses to SARS-CoV infec...
Main Authors: | Li, C, Wu, H, Yan, H, Ma, S, Wang, L, Zhang, M, Tang, X, Temperton, N, Weiss, R, Brenchley, J, Douek, D, Mongkolsapaya, J, Tran, B, Lin, C, Screaton, G, Hou, J, Mcmichael, A, Xu, X |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
Similar Items
-
TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL.
by: Screaton, G, et al.
Published: (1997) -
Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL.
by: Mongkolsapaya, J, et al.
Published: (1998) -
Which dengue vaccine approach is the most promising, and should we be concerned about enhanced disease after vaccination?
The challenges of a dengue vaccine
by: Screaton, G, et al.
Published: (2018) -
Evolution of neurovirulent Zika virus
by: Screaton, G, et al.
Published: (2017) -
CTLs target Th cells that acquire bystander MHC class I-peptide complex from APCs.
by: Cox, J, et al.
Published: (2007)